Institutional investors hold a majority ownership of AGN through the 101.09% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended June 2014, these large investors purchased a net $25.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PERSHING SQUARE CAPITAL MANAGEME... Bought 28.3 Million shares of Allergan Inc
ARGENTIÈRE CAPITAL AG Bought 249.2 Thousand shares of Allergan Inc